Back
Y-mAbs Therapeutics Stock Predictions
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
29
YMAB
Y-mAbs Therapeutics
Last Price:
$4.23
Seasonality Move:
-4.07%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report NowY-mAbs Therapeutics Stock Forecast
-
Is Y-mAbs Therapeutics Stock Undervalued?The current Y-mAbs Therapeutics [YMAB] share price is $4.21. The Score for YMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
YMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Y-mAbs Therapeutics Stock Go Up Next Year?
Data Unavailable
Y-mAbs Therapeutics Stock Rating
Data Unavailable
Y-mAbs Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ymabs.com
52-Week Data
52-Week High:
16.11
52-Week Low:
3.55
Prediction Charts
Market Cap:
190.7M
Price in USD:
4.21
Volume:
145.3K
Beta:
0.82
Technical Analysis
SMA50:
4.45
SMA100:
4.75
SMA200:
7.82
52-Wk Change:
-62.71%
Stock Predictions
-
Is Y-mAbs Therapeutics stock public?Yes, Y-mAbs Therapeutics is a publicly traded company.
-
What is the Y-mAbs Therapeutics stock quote today?The Y-mAbs Therapeutics stock price is 4.21 USD today.
-
How to buy Y-mAbs Therapeutics stock online?You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-17 | 4.93 | 4.80 | 4.98 | 4.74 |
| Jun-18 | 4.79 | 4.63 | 4.96 | 4.55 |
| Jun-20 | 4.63 | 4.41 | 4.70 | 3.90 |
| Jun-23 | 4.37 | 4.72 | 4.75 | 4.28 |
| Jun-24 | 4.78 | 5.13 | 5.33 | 4.68 |
| Jun-25 | 5.19 | 4.91 | 5.24 | 4.87 |
| Jun-26 | 4.92 | 4.80 | 4.97 | 4.73 |
| Jun-27 | 4.78 | 4.70 | 4.78 | 4.58 |
| Jun-30 | 4.71 | 4.51 | 4.73 | 4.48 |
| Jul-1 | 4.51 | 4.41 | 4.62 | 4.40 |
| Jul-2 | 4.41 | 4.26 | 4.57 | 4.25 |
| Jul-3 | 4.31 | 4.30 | 4.33 | 4.18 |
| Jul-7 | 4.27 | 4.22 | 4.33 | 4.10 |
| Jul-8 | 4.24 | 4.21 | 4.40 | 4.20 |
Y-mAbs Therapeutics Earnings
Data Unavailable
Y-mAbs Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.09 per share.
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.